Literature DB >> 30042798

The Case of IgG4-Related Ophthalmic Disease with Perivascular Lesions of Superior Ophthalmic Vein Associated with Optic Nerve Disturbance.

Azusa Yamagishi1, Toshiyuki Oshitari1, Ayako Tawada1, Takayuki Baba1, Shuichi Yamamoto1.   

Abstract

A 61-year-old man with hyperthyroidism had exophthalmos with dilated conjunctival vessels in both eyes. Magnetic resonance imaging showed that the superior ophthalmic veins had a funicular-like appearance. Cerebral angiography showed no blood flow from both internal carotid arteries to the cavernous sinus, thus excluding a carotid-cavernous fistula. Blood tests showed an elevation of IgG4 (281 mg/dl), and a IgG4-related ophthalmic disease was considered. Steroid pulse therapy was performed, and all of the abnormal findings were improved. We concluded that this was a rare case of IgG4-related ophthalmic disease with perivascular lesions of the superior ophthalmic vein associated with optic nerve disturbance.

Entities:  

Keywords:  Carotid-cavernous fistula; IgG4-related ophthalmic disease; steroid pulse therapy; superior ophthalmic vein; thyroid-associated orbitopathy

Year:  2017        PMID: 30042798      PMCID: PMC6056214          DOI: 10.1080/01658107.2017.1394328

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  7 in total

1.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.

Authors:  Hisanori Umehara; Kazuichi Okazaki; Yasufumi Masaki; Mitsuhiro Kawano; Motohisa Yamamoto; Takako Saeki; Shoko Matsui; Tadashi Yoshino; Shigeo Nakamura; Shigeyuki Kawa; Hideaki Hamano; Terumi Kamisawa; Toru Shimosegawa; Akira Shimatsu; Seiji Nakamura; Tetsuhide Ito; Kenji Notohara; Takayuki Sumida; Yoshiya Tanaka; Tsuneyo Mimori; Tsutomu Chiba; Michiaki Mishima; Toshifumi Hibi; Hirohito Tsubouchi; Kazuo Inui; Hirotaka Ohara
Journal:  Mod Rheumatol       Date:  2012-01-05       Impact factor: 3.023

2.  The diagnostic utility of serum IgG4 concentrations in IgG4-related disease.

Authors:  Mollie N Carruthers; Arezou Khosroshahi; Tamara Augustin; Vikram Deshpande; John H Stone
Journal:  Ann Rheum Dis       Date:  2014-03-20       Impact factor: 19.103

Review 3.  Diagnostic criteria for IgG4-related ophthalmic disease.

Authors:  Hiroshi Goto; Masayuki Takahira; Masahiro Takahira; Atsushi Azumi
Journal:  Jpn J Ophthalmol       Date:  2014-11-14       Impact factor: 2.447

4.  Serum Immunoglobulin G4 levels are elevated in patients with Graves' ophthalmopathy.

Authors:  Emre Bozkirli; Okan Sefa Bakiner; Emine Duygu Ersozlu Bozkirli; Filiz Eksi Haydardedeoglu; Selcuk Sizmaz; Aysenur Izol Torun; Melek Eda Ertorer
Journal:  Clin Endocrinol (Oxf)       Date:  2014-12-12       Impact factor: 3.478

5.  Location and frequency of lesions in patients with IgG4-related ophthalmic diseases.

Authors:  Yuka Sogabe; Koh-ichi Ohshima; Atsushi Azumi; Masayuki Takahira; Satoru Kase; Hideki Tsuji; Hiroshi Yoshikawa; Tetsuya Nakamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-03       Impact factor: 3.117

6.  A prevalence study of IgG4-related ophthalmic disease in Japan.

Authors: 
Journal:  Jpn J Ophthalmol       Date:  2013-08-07       Impact factor: 2.447

7.  Serum total IgG and IgG4 levels in thyroid eye disease.

Authors:  Aileen Sy; Rona Z Silkiss
Journal:  Int Med Case Rep J       Date:  2016-10-20
  7 in total
  3 in total

1.  IgG4-related orbitopathy as an important differential diagnosis of advanced silent sinus syndrome.

Authors:  M Jurkov; H Olze; F Klauschen; E Bertelmann; U Schneider; P Arens
Journal:  HNO       Date:  2020-01       Impact factor: 1.284

2.  Immunoglobulin G4-related disease of the cavernous sinus with orbit invasion - A case report.

Authors:  Julie Mayeku; Jeremy Deisch; Miguel Angel Lopez-Gonzalez
Journal:  Surg Neurol Int       Date:  2021-11-08

Review 3.  [IgG4-Related Orbitopathy as an Important Differential Diagnosis of Advanced Silent Sinus Syndrome. German version].

Authors:  M Jurkov; H Olze; F Klauschen; E Bertelmann; U Schneider; P Arens
Journal:  HNO       Date:  2020-11       Impact factor: 1.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.